65 The ISTH-BAT score and outcomes after EA in women with HMB 23. Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen. 2012;141(1):2-18. 24. Ragni MV, Machin N, Malec LM, James AH, Kessler CM, Konkle BA, et al. Von Willebrand factor for menorrhagia: a survey and literature review. Haemophilia. 2016;22(3):397-402. 25. Lavin M, Aguila S, Dalton N, Nolan M, Byrne M, Ryan K, et al. Significant gynecological bleeding in women with low von Willebrand factor levels. Blood Adv. 2018;2(14):1784-91. 26. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201(1):12 e1-8. 27. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5(1):408. 28. Care CoAH. Committee Opinion No.580: von Willebrand disease in women. Obstetrics Gynecology. 2013;2013 dec(6):1368-73. 29. Eising HP, Roest M, de Groot PG, Huskens D, Konings J, Urbanus RT, et al. High prevalence of reduced thrombin generation and/or decreased platelet response in women with unexplained heavy menstrual bleeding. Int J Lab Hematol. 2018;40(3):26875. 30. Eising HP, Sanders YV, de Meris J, Leebeek FWG, Meijer K. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease. Haemophilia. 2018;24(6):950-6. 31. Beelen P, van den Brink MJ, Herman MC, Geomini P, Dekker JH, Duijnhoven RG, et al. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. Am J Obstet Gynecol. 2021;224(2):187 e1- e10. 32. van den Brink MJ, Wiewel-Verschueren S, Beelen P, van Borselen JW, Bongers MY, Lukens MV, et al. Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: An exploratory study. Haemophilia. 2021;27(6):e756-e9. 33. Beelen P, Reinders IMA, Scheepers WFW, Herman MC, Geomini P, van Kuijk SMJ, et al. Prognostic Factors for the Failure of Endometrial Ablation: A Systematic Review and Meta-analysis. Obstet Gynecol. 2019;134(6):1269-81. 34. Wyatt SN, Banahan T, Tang Y, Nadendla K, Szychowski JM, Jenkins TR. Effect of Radiofrequency Endometrial Ablation on Dysmenorrhea. J Minim Invasive Gynecol. 2016;23(7):1163-6. 35. Punt MC, Ruigrok ND, Bloemenkamp KWM, Uitslager N, Urbanus RT, Groot E, et al. Prevalence, burden and treatment effects of vaginal bleeding in women with (suspected) congenital platelet disorders throughout life: a cross-sectional study. Br J Haematol. 2022;196(1):215-23. 36. El-Nashar SA, Hopkins MR, Barnes SA, Pruthi RK, Gebhart JB, Cliby WA, et al. Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and systematic review. Am J Obstet Gynecol. 2010;202(4):348 e1-7. 4
RkJQdWJsaXNoZXIy MTk4NDMw